Esomeprazole and omeprazole may boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) resulting in improved adverse effects for example drowsiness, although the clinical relevance is small in the majority of individuals – monitor the affected individual for adverse effects (e.If affected individual can not resume their … Read More